Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population
- PMID: 20368174
- DOI: 10.1126/scitranslmed.3000237
Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population
Abstract
Gout based on hyperuricemia is a common disease with a genetic predisposition, which causes acute arthritis. The ABCG2/BCRP gene, located in a gout-susceptibility locus on chromosome 4q, has been identified by recent genome-wide association studies of serum uric acid concentrations and gout. Urate transport assays demonstrated that ABCG2 is a high-capacity urate secretion transporter. Sequencing of the ABCG2 gene in 90 hyperuricemia patients revealed several nonfunctional ABCG2 mutations, including Q126X. Quantitative trait locus analysis of 739 individuals showed that a common dysfunctional variant of ABCG2, Q141K, increases serum uric acid. Q126X is assigned to the different disease haplotype from Q141K and increases gout risk, conferring an odds ratio of 5.97. Furthermore, 10% of gout patients (16 out of 159 cases) had genotype combinations resulting in more than 75% reduction of ABCG2 function (odds ratio, 25.8). Our findings indicate that nonfunctional variants of ABCG2 essentially block gut and renal urate excretion and cause gout.
Similar articles
-
ABCG2/BCRP dysfunction as a major cause of gout.Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1117-28. doi: 10.1080/15257770.2011.633954. Nucleosides Nucleotides Nucleic Acids. 2011. PMID: 22132966
-
Identification of ABCG2 dysfunction as a major factor contributing to gout.Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1098-104. doi: 10.1080/15257770.2011.627902. Nucleosides Nucleotides Nucleic Acids. 2011. PMID: 22132963
-
ABCG2 dysfunction increases the risk of renal overload hyperuricemia.Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):266-74. doi: 10.1080/15257770.2013.866679. Nucleosides Nucleotides Nucleic Acids. 2014. PMID: 24940678
-
[Recent progress and prospects for research on urate efflux transporter ABCG2].Nihon Rinsho. 2014 Apr;72(4):757-65. Nihon Rinsho. 2014. PMID: 24796111 Review. Japanese.
-
An update on the genetic architecture of hyperuricemia and gout.Arthritis Res Ther. 2015 Apr 10;17(1):98. doi: 10.1186/s13075-015-0609-2. Arthritis Res Ther. 2015. PMID: 25889045 Free PMC article. Review.
Cited by
-
Jump into a New Fold-A Homology Based Model for the ABCG2/BCRP Multidrug Transporter.PLoS One. 2016 Oct 14;11(10):e0164426. doi: 10.1371/journal.pone.0164426. eCollection 2016. PLoS One. 2016. PMID: 27741279 Free PMC article.
-
Immunohistochemical studies of organic anion transporters and urate transporter 1 expression in human salivary gland.Acta Odontol Scand. 2013 Mar;71(2):312-6. doi: 10.3109/00016357.2012.680904. Epub 2012 May 8. Acta Odontol Scand. 2013. PMID: 22564045 Free PMC article.
-
Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications.Front Pharmacol. 2019 Mar 5;10:208. doi: 10.3389/fphar.2019.00208. eCollection 2019. Front Pharmacol. 2019. PMID: 30890942 Free PMC article. Review.
-
The pharmacological impact of ATP-binding cassette drug transporters on vemurafenib-based therapy.Acta Pharm Sin B. 2014 Apr;4(2):105-11. doi: 10.1016/j.apsb.2013.12.001. Epub 2014 Jan 13. Acta Pharm Sin B. 2014. PMID: 26579371 Free PMC article. Review.
-
Cichorium intybus L. promotes intestinal uric acid excretion by modulating ABCG2 in experimental hyperuricemia.Nutr Metab (Lond). 2017 Jun 13;14:38. doi: 10.1186/s12986-017-0190-6. eCollection 2017. Nutr Metab (Lond). 2017. PMID: 28630638 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases